After several years of exciting developments in melanoma therapy, progress continued throughout 2015 with FDA approved PD-1 immunotherapy treatments and the first-ever approved oncolytic virus therapy drug, Imlygic. Also noteworthy for those with advanced melanoma, a promising new combination treatment which includes an imiquimod/topical therapy has been found to be highly effective in treating patients with skin metastases. The results have been so encouraging that there will most likely be more news on this topic as 2016 progresses.
CancerConnect News coverage of advances in the management of melanoma included the following key developments in 2015:
2015 FDA News
2015 Melanoma Research News
Other 2015 Melanoma News
LEARNING MORE ABOUT MELANOMA
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?
- Sign up for monthly newsletters on melanoma here.
- Get the facts about melanoma here.
- Join ongoing discussions with other individuals affected by melanoma in the CancerConnect private online support group here.
- Follow CancerConnect on Facebook and Twitter.
Copyright © 2018 CancerConnect. All Rights Reserved.